Montecito Bank & Trust Has $5.42 Million Position in The Procter & Gamble Company (NYSE:PG)

Montecito Bank & Trust increased its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 25.3% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 31,276 shares of the company’s stock after purchasing an additional 6,319 shares during the period. Procter & Gamble makes up 0.9% of Montecito Bank & Trust’s portfolio, making the stock its 25th biggest position. Montecito Bank & Trust’s holdings in Procter & Gamble were worth $5,417,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in PG. Itau Unibanco Holding S.A. acquired a new stake in shares of Procter & Gamble during the second quarter worth approximately $28,000. Fairway Wealth LLC bought a new stake in Procter & Gamble during the 2nd quarter worth approximately $29,000. Ruedi Wealth Management Inc. raised its position in Procter & Gamble by 64.7% in the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after purchasing an additional 77 shares during the last quarter. POM Investment Strategies LLC acquired a new position in Procter & Gamble in the second quarter worth $34,000. Finally, Quest Partners LLC bought a new stake in shares of Procter & Gamble during the second quarter worth $36,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Procter & Gamble

In other news, CEO Jon R. Moeller sold 72,174 shares of the firm’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $171.01, for a total value of $12,342,475.74. Following the completion of the sale, the chief executive officer now directly owns 263,158 shares of the company’s stock, valued at $45,002,649.58. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. In other Procter & Gamble news, CEO Jon R. Moeller sold 31,797 shares of the firm’s stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $5,380,688.34. Following the completion of the sale, the chief executive officer now directly owns 300,777 shares in the company, valued at $50,897,483.94. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Jon R. Moeller sold 72,174 shares of the company’s stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $171.01, for a total value of $12,342,475.74. Following the completion of the transaction, the chief executive officer now directly owns 263,158 shares in the company, valued at $45,002,649.58. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 385,771 shares of company stock worth $65,610,975. Insiders own 0.18% of the company’s stock.

Procter & Gamble Trading Down 2.9 %

NYSE PG opened at $160.99 on Thursday. The stock has a market capitalization of $379.14 billion, a price-to-earnings ratio of 27.76, a PEG ratio of 3.57 and a beta of 0.42. The Procter & Gamble Company has a 52 week low of $142.50 and a 52 week high of $177.94. The stock’s 50 day moving average price is $171.29 and its two-hundred day moving average price is $168.13. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company’s revenue for the quarter was down .6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.83 EPS. As a group, analysts anticipate that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a $1.0065 dividend. The ex-dividend date is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.50%. Procter & Gamble’s payout ratio is 69.48%.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on PG. Citigroup raised their price target on shares of Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Morgan Stanley lifted their target price on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Deutsche Bank Aktiengesellschaft boosted their target price on Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Barclays lowered Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective for the company. in a research report on Monday, September 30th. Finally, DA Davidson upped their target price on shares of Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a research report on Monday, October 21st. Nine investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $177.00.

View Our Latest Stock Report on Procter & Gamble

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.